Molecular imaging of gastroenteropancreatic neuroendocrine tumors: current status and future directions

CM Deroose, E Hindié, E Kebebew… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Through diagnostic imaging and peptide receptor radionuclide therapy, nuclear medicine
has earned a major role in gastroenteropancreatic neuroendocrine tumors (GEP NETs) …

Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies

L Lee, T Ito, RT Jensen - Expert review of anticancer therapy, 2018 - Taylor & Francis
Introduction: Recently, there have been a number of advances in imaging pancreatic
neuroendocrine tumors (panNETs), as well as other neuroendocrine tumors (NETs), which …

Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA

MF Bozkurt, I Virgolini, S Balogova, M Beheshti… - European journal of …, 2017 - Springer
Abstract Purpose & Methods Neuroendocrine neoplasms are a heterogenous group of
tumours, for which nuclear medicine plays an important role in the diagnostic work-up as …

Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy …

K Antwi, M Fani, T Heye, G Nicolas… - European journal of …, 2018 - Springer
Purpose Benign insulinomas are the most prevalent cause of endogenous
hyperinsulinaemic hypoglycaemia (EHH) in adults, and because of their small size are …

Innovative imaging of insulinoma: the end of sampling? A review

E Christ, K Antwi, M Fani, D Wild - Endocrine-related cancer, 2020 - erc.bioscientifica.com
Receptors for the incretin glucagon-like peptide-1 (GLP-1R) have been found
overexpressed in selected types of human tumors and may, therefore, play an increasingly …

Role of PET/CT and therapy management of pancreatic neuroendocrine tumors

D Calabrò, G Argalia, V Ambrosini - Diagnostics, 2020 - mdpi.com
Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with
neuroendocrine differentiation that show peculiar clinical and histomorphological features …

Exendin‐4‐based imaging in insulinoma localization: systematic review and meta‐analysis

R Shah, R Garg, M Majmundar… - Clinical …, 2021 - Wiley Online Library
Background and context Glucagon‑like peptide‑1 receptor (GLP‐1 R) based imaging has
shown higher sensitivity for insulinoma localization as compared to other …

Molecular imaging of β-cells: diabetes and beyond

W Wei, EB Ehlerding, X Lan, QY Luo, W Cai - Advanced drug delivery …, 2019 - Elsevier
Since diabetes is becoming a global epidemic, there is a great need to develop early β-cell
specific diagnostic techniques for this disorder. There are two types of diabetes (ie, type 1 …

Surgical management of insulinoma over three decades

A de Carbonnières, A Challine, AS Cottereau, R Coriat… - HPB, 2021 - Elsevier
Background This paper reports our experience of the perioperative management of patients
with sporadic, non-malignant, pancreatic insulinoma. Methods A retrospective monocentric …

Novel PET tracers: added value for endocrine disorders

S Bergeret, J Charbit, C Ansquer, G Bera, P Chanson… - Endocrine, 2019 - Springer
Nuclear medicine has been implicated in the diagnosis and treatment of endocrine
disorders for several decades. With recent development of PET tracers, functional imaging …